SCHRODER INVESTMENT MANAGEMENT GROUP - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is and the CUSIP is 462222AD2. A total of 43 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
SCHRODER INVESTMENT MANAGEMENT GROUP ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$6,164,115
-16.7%
6,300,000
-19.2%
0.01%
-18.2%
Q2 2023$7,397,855
+4.0%
7,800,0000.0%0.01%0.0%
Q1 2023$7,111,681
-6.0%
7,800,000
-4.4%
0.01%
-8.3%
Q4 2022$7,567,700
+68.1%
8,156,000
+79.0%
0.01%
+71.4%
Q3 2022$4,502,0004,556,0000.01%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
STEELHEAD PARTNERS LLC 54,800,000$53,728,9343.15%
CSS LLC/IL 27,690,000$27,111,9721.78%
BRAIDWELL LP 52,740,000$51,764,3101.64%
Sonora Investment Management Group, LLC 12,648,000$12,375,1971.06%
CAMDEN ASSET MANAGEMENT L P /CA 24,900,000$24,314,8500.90%
DeepCurrents Investment Group LLC 20,000,000$19,514,0730.85%
Magnetar Financial LLC 28,500,000$27,924,1660.71%
TENOR CAPITAL MANAGEMENT Co., L.P. 32,000,000$31,366,1230.67%
MACKAY SHIELDS LLC 23,902,000$24,063,6470.66%
SHENKMAN CAPITAL MANAGEMENT INC 8,210,000$8,155,8490.61%
View complete list of IONIS PHARMACEUTICALS INC shareholders